These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11305068)

  • 21. Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer.
    Zambelli A; Robustelli della Cuna FS; Ponchio L; Ucci G; Da Prada GA; Robustelli della Cuna G
    Breast Cancer Res Treat; 2000 Jun; 61(3):241-7. PubMed ID: 10966000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vinorelbine-related cardiac events: a meta-analysis of randomized clinical trials.
    Lapeyre-Mestre M; Gregoire N; Bugat R; Montastruc JL
    Fundam Clin Pharmacol; 2004 Feb; 18(1):97-105. PubMed ID: 14748761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute pain at tumor recurrence site induced by vinorelbine infusion].
    Shibahara H; Hiramatsu Y
    Kyobu Geka; 2013 Jul; 66(7):567-9. PubMed ID: 23917136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
    Uoshima N; Yoshioka K; Tegoshi H; Wada S; Fujiwara Y; Satake N; Kasamatsu Y; Yokoho S
    Intern Med; 2001 Aug; 40(8):779-82. PubMed ID: 11518124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer.
    Udom DI; Vigushin DM; Linardou H; Graham H; Palmieri C; Coombes RC
    Eur J Cancer; 2000 Jan; 36(2):177-82. PubMed ID: 10741275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer.
    Ibrahim NK; Valero V; Theriault RL; Willey J; Walters RS; Buzdar AU; Booser DJ; Hortobagyi GN
    Am J Clin Oncol; 2000 Apr; 23(2):117-21. PubMed ID: 10776969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial.
    Campisi C; Fabi A; Papaldo P; Tomao S; Massidda B; Zappala A; Ionta MT; Cognetti F
    Cancer Chemother Pharmacol; 1999; 44 Suppl():S1-4. PubMed ID: 10602901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly schedule of vinorelbine in pretreated breast cancer patients.
    Nisticò C; Garufi C; Milella M; Vaccaro A; D'Ottavio AM; Fabi A; Pace A; Bove L; Tropea F; Marsella A; Izzo F; D'Attino RM; Ferraresi V; De Marco S; Terzoli E
    Breast Cancer Res Treat; 2000 Feb; 59(3):223-9. PubMed ID: 10832592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic treatment of local reactions to i.v. vinorelbine: a randomized study.
    Quant E; Bergman B
    Support Care Cancer; 2012 Aug; 20(8):1737-44. PubMed ID: 21922202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.
    Rossi A; Gridelli C; Gebbia V; Rosati G; Tortoriello A; Maione P; Borsellino N; Rossi N; Pisano A; Colantuoni G; Iaffaioli RV; Castaldo V; Manzione L
    Anticancer Res; 2003; 23(2C):1657-64. PubMed ID: 12820437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma.
    Feun LG; Savaraj N; Hurley J; Marini A; Lai S
    Cancer; 2000 Feb; 88(3):584-8. PubMed ID: 10649251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II trial of fractionated vinorelbine/doxorubicin as first-line therapy for advanced breast cancer.
    Hegg R; Costa MA; Perdicaris M; Delgado GL; Cabral-Filho S; Malzyner A; Caponero R; Yamagushi N; Novaes N; Anelli A; Correa M; Nader L; Andrade C
    Curr Med Res Opin; 2001; 16(4):225-34. PubMed ID: 11268706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine.
    Hoff PM; Valero V; Ibrahim N; Willey J; Hortobagyi GN
    Cancer; 1998 Mar; 82(5):965-9. PubMed ID: 9486588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.
    Lacava JA; Leone BA; Machiavelli M; Romero AO; Perez JE; Elem YL; Ferreyra R; Focaccia G; Suttora G; Salvadori MA; Cuevas MA; Acuña LR; Acuña JR; Langhi M; Amato S; Castaldi J; Arroyo A; Vallejo CT
    J Clin Oncol; 1997 Feb; 15(2):604-9. PubMed ID: 9053483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
    Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma. A phase II study.
    Testolin A; Recher G; Cristoferi V; Gasparini G
    Invest New Drugs; 1994; 12(3):231-4. PubMed ID: 7896542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience.
    Bruno S; Puerto VL; Mickiewicz E; Hegg R; Texeira LC; Gaitan L; Martinez L; Fernandez O; Otero J; Kesselring G
    Am J Clin Oncol; 1995 Oct; 18(5):392-6. PubMed ID: 7572754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral versus intravenous vinorelbine: clinical safety profile.
    Gebbia V; Puozzo C
    Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
    Pieńkowski T; Jagiello-Gruszfeld A
    Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of vinorelbine in advanced and metastatic breast cancer].
    Nishikawa N; Ohmura T; Suzuki Y; Kameshima H; Kutomi G; Hirata K
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):577-80. PubMed ID: 21498984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.